Intuitive Surgical, Inc.

🇺🇸NASDAQ Global Select
Back to all articles
Intuitive Surgical, Inc. stock analysis ISRG overview
Very Bullish +76

ISRG Stock Price, Quote & Chart | INTUITIVE SURGICAL INC (NASDAQ:ISRG) - ChartMill

📉 Intuitive Surgical Inc. (ISRG) stock closed at $470.99, reflecting a 2.33% decline in the most recent trading session.

📈 Despite the daily drop, ISRG has gained 4.05% over the past month while declining 11.04% over the last year.

🚀 ChartMill identifies ISRG as part of several top-performing screens, including fastest growing stocks and revenue growth leaders.

⚠️ Technical analysis gives ISRG a low rating of 1 out of 10 due to its underperformance relative to the broader market this year.

💎 Fundamental analysis rates ISRG highly at 7 out of 10, reflecting its strong health and profitability within the healthcare industry.

📅 On April 20, 2026, the company reported earnings that beat analyst expectations by 16.77% for EPS and 3.89% for revenue.

🎯 With 41 analysts covering the stock, the consensus price target stands at $615.86, implying potential upside of roughly 30.76%.

📊 Analysts forecast an EPS growth of 14.43% and revenue growth of 15.78% for the upcoming year.

💹 The company currently trades at a price-to-earnings (PE) ratio of 48.96 based on non-GAAP earnings per share of $9.62.

📉 ISRG has not reported any dividend payments to shareholders, relying instead on capital appreciation and growth prospects.

🤖 The firm specializes in robotic-assisted surgical solutions, with its flagship da Vinci system used for various surgical specialties.

🔬 Intuitive Surgical also utilizes the Ion endoluminal system for minimally invasive diagnostics and lung biopsies.

🏢 Headquartered in Sunnyvale, California, the company employs 17,021 full-time staff and has been publicly listed since 2000.

⚠️ Investors should consult the Technical and Fundamental Analysis tabs for deeper insights into investment suitability.

💼 Full profile data is restricted to registered users who can view more detailed charts and competitor comparisons.

Bullish Signals
  • ISRG is included in multiple ChartMill growth screens, including fastest growing stocks, revenue growth leaders, and highest analyst upside stock lists.
  • On April 20, 2026, ISRG beat EPS expectations by 16.77% and beat revenue expectations by 3.89% with reported EPS of $2.50 and revenue of $2.77 billion.
  • Analysts are projecting an average price target of $615.86 USD, implying a potential 30.76% upside from the current price of $470.99.
  • Over the last twelve months, non-GAAP EPS grew by 25.92% compared to the previous year with a trailing EPS of $9.62.
  • Analysts expect strong future growth with projected EPS growth of 14.43% and revenue growth of 15.78% for the coming year.
  • ISRG maintains an outstanding health and profitability rating in its fundamental assessment, scoring a 7 out of 10 on ChartMill fundamentals.
  • The company employs 17,021 full-time employees and operates a comprehensive ecosystem of robotic-assisted surgical solutions including the da Vinci and Ion systems.
Risk Factors
  • Today ISRG stock price decreased by -2.33%, showing short-term weakness despite longer-term gains.
  • The company has not paid a dividend to shareholders.
  • ChartMill assigns a low technical rating of 1 out of 10, indicating weak technical performance compared to the broader market where 79.25% of stocks are performing better.
  • The PE ratio stands at 48.96, which is relatively high and may be overvalued relative to earnings.
  • Over the past year, ISRG's stock price has decreased by -11.04%, demonstrating a notable annual decline despite appearing in multiple positive growth screens.
  • Analyst average price target of 615.86 USD implies a required 30.76% increase to reach targets, which is aggressive and may not materialize if market sentiment worsens.
Full Analysis
The stock price of Intuitive Surgical Inc., ticker ISRG (NASDAQ), is currently trading at 470.99 USD, reflecting a decline of 2.33% in the most recent session. Over the past year, the share price has decreased by 11.04%, though it has gained 4.05% over the last month. The company appears on several ChartMill screener lists, including those for fastest growing stocks, revenue growth leaders, and highest analyst upside. Conversely, ChartMill assigns a low technical rating of 1 out of 10 to the stock, indicating that 79.25% of all stocks are performing better than ISRG in terms of yearly performance. From a fundamental perspective, ISRG holds a strong rating of 7 out of 10 and is recognized for outstanding health and profitability within its industry. Analysts have analyzed the company with an average price target of 615.86 USD, implying an expected price increase of 30.76% over the current market value. On April 20, 2026, Intuitive Surgical reported an earnings per share (EPS) of 2.5 and revenue of 2.77 billion, surpassing analyst expectations by 16.77% and 3.89%, respectively. For the upcoming year, analysts forecast EPS growth of 14.43% and revenue growth of 15.78%. Intuitive Surgical Inc., headquartered in Sunnyvale, California with approximately 17,021 full-time employees, was founded as a public company through its initial public offering on June 13, 2000. The firm specializes in robotic-assisted surgical solutions and invasive care, offering a comprehensive ecosystem of products including the da Vinci surgical systems for various specialties and the Ion endoluminal system for minimally invasive biopsies. Over the trailing twelve months, the company reported a non-GAAP EPS of 9.62, which represents a 25.92% increase compared to the previous year. The stock currently has a price-to-earnings ratio of 48.96 and does not pay a dividend.